ICPO Foundation kooperiert mit Munich Precision Oncology (MPO), um weltweit spezialisierte Theranostik-Zentren zu etablieren
November 19, 2024 01:30 ET
|
ICPO Foundation
Das Münchener Pilotzentrum wird als funktionaler Demonstrator für die ICPO dienen. Die Foundation stellt Akkreditierungsrichtlinien und zertifizierte Schulungen bereit, um die Behandlungserfolge der...
ICPO Foundation partners with Munich Precision Oncology (MPO) to establish dedicated theranostics centers globally
November 19, 2024 01:30 ET
|
ICPO Foundation
The Munich pilot center will serve as a functional demonstrator for ICPO. The Foundation will provide accreditation guidelines and certified training for improved patient outcomes. November 19, 2024...
Trent Renta Promoted to Chief Operating Officer at Olansky Dermatology & Aesthetics in Atlanta, Georgia
November 18, 2024 16:44 ET
|
Olansky Dermatology & Aesthetics
Trent Renta promoted to Chief Operating Officer
at Olansky Dermatology & Aesthetics in Atlanta, Georgia.
University of Miami will invest $30 million to to fuel neuroscience and aging research
October 17, 2024 11:35 ET
|
University of Miami
CORAL GABLES, Fla., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Demonstrating its commitment to excellence as a member of the Association of American Universities and number one in the state for National...
Forbion raises in excess of €2 billion for two new funds
October 15, 2024 01:00 ET
|
Forbion
Forbion’s largest fundraising to date with Forbion’s Growth Opportunities Fund III raising €1.2 billion & Forbion Ventures Fund VII raising €890 million
ICPO Foundation geht eine Partnerschaft mit der International Atomic Energy Agency (IAEA) ein
October 10, 2024 04:15 ET
|
ICPO Foundation
Die Parteien kooperieren weltweit im Bereich der therapeutischen klinischen Anwendungen der Nuklearmedizin in der Onkologie. 10. Oktober 2024 – Wiesbaden, Deutschland. Heute kündigte die...
ICPO Foundation partners with the International Atomic Energy Agency (IAEA)
October 10, 2024 04:15 ET
|
ICPO Foundation
The parties cooperate in the area of therapeutic clinical applications of nuclear medicine in oncology worldwide. October 10, 2024 – Wiesbaden, Germany. Today, the International Centers for...
KabaFusion Selected by GC Biopharma USA, Inc. as a Limited Distribution Partner for Partner of ALYGLO™ for Adults With Primary Humoral Immunodeficiency (PI)
July 30, 2024 10:00 ET
|
KabaFusion
CERRITOS, Calif. and LEXINGTON, Mass., July 30, 2024 (GLOBE NEWSWIRE) -- KabaFusion, a nationally recognized leader in home infusion, has been selected by GC Biopharma USA, Inc. as a limited...
RS BioTherapeutics Announces Research Collaboration with University of Colorado School of Medicine
July 08, 2024 10:00 ET
|
RS BioTherapeutics
CUMBERLAND, Md., July 08, 2024 (GLOBE NEWSWIRE) -- RS BioTherapeutics, whose mission is to develop life-changing medicines for the millions of people suffering from deadly lung diseases...
CBIH Charts Path to Future Leadership in Cannabis Medicine
July 08, 2024 08:00 ET
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
A letter from our desk HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Since the start of the year, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) has embarked on a transformative journey...